| 18.52 Data as of Jun 19 |  -0.33 / -1.75%Today’s Change | 14.41 Today|||52-Week Range 27.25 | -9.61% Year-to-Date |
| Does Restless Legs Syndrome Really Shorten Life Span? Jun 17 / MotleyFool.com | Impax Reduces Workforce - Analyst Blog Jun 06 / Zacks.com |
| Previous close | 18.85 |
| Today’s open | 18.80 |
| Day’s range | -- - -- |
| Volume | 627,950 |
| Average volume (3 months) | 1,041,347 |
| Market cap | $1.3B |
| Dividend yield | -- |
| Earnings growth (last year) | -15.46% |
| Earnings growth (this year) | -88.96% |
| Earnings growth (next 5 years) | +30.10% |
| Revenue growth (last year) | +13.41% |
| P/E ratio | 8.5 |
| Price/Sales | 2.31 |
| Price/Book | 1.83 |
| Today’s change | Today’s % change | |
|---|---|---|
| AKRXAkorn Inc | -0.25 | -1.85% |
| SRPTSarepta Therapeutics... | +1.63 | +4.27% |
| VVUSVIVUS Inc | +0.43 | +3.12% |
| TSROTESARO Inc | -1.57 | -4.36% |
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | $0.05 |
| Annual revenue (last year) | $581.7M |
| Annual profit (last year) | $55.9M |
| Net profit margin | 9.61% |
Sector Health Technology |
Industry Pharmaceuticals: Generic |
President, Chief Executive Officer & Director Chung-Chiang Hsu, PhD |
Chief Financial Officer & Senior Vice President Bryan M. Reasons, MBA, CPA |
Corporate headquarters Hayward, California |
.
